Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 03, 2013

Bristol-Myers Squibb Company v. Genentech, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 07, 2013

    Bristol-Myers Seeks To Bust Genentech Cancer Drug Patents

    Bristol-Myers Squibb Co. on Friday filed suit in California federal court that two Genentech Inc. patents relating to blood cancer treatment are invalid and that Bristol-Myers Squibb's antibody-producing cancer drugs Erbitux and Yervoy do not infringe those patents.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login